The Manufacturers Life Insurance Company reduced its position in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 4.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 69,878 shares of the health services provider’s stock after selling 2,903 shares during the period. The Manufacturers Life Insurance Company owned 0.12% of Maximus worth $6,510,000 as of its most recent SEC filing.
Several other large investors also recently modified their holdings of MMS. Algert Global LLC raised its holdings in Maximus by 15.1% in the 3rd quarter. Algert Global LLC now owns 166,802 shares of the health services provider’s stock worth $15,539,000 after purchasing an additional 21,831 shares in the last quarter. Cerity Partners LLC increased its position in shares of Maximus by 1.0% during the third quarter. Cerity Partners LLC now owns 111,915 shares of the health services provider’s stock valued at $10,426,000 after buying an additional 1,107 shares during the period. Citigroup Inc. raised its stake in Maximus by 143.3% in the third quarter. Citigroup Inc. now owns 59,448 shares of the health services provider’s stock worth $5,538,000 after buying an additional 35,012 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in Maximus by 12.4% in the third quarter. Charles Schwab Investment Management Inc. now owns 929,066 shares of the health services provider’s stock worth $86,552,000 after buying an additional 102,350 shares during the period. Finally, Intech Investment Management LLC boosted its position in Maximus by 30.5% during the 3rd quarter. Intech Investment Management LLC now owns 23,832 shares of the health services provider’s stock valued at $2,220,000 after acquiring an additional 5,566 shares in the last quarter. 97.21% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Separately, StockNews.com lowered Maximus from a “buy” rating to a “hold” rating in a research report on Thursday, November 28th.
Insider Activity
In other Maximus news, insider Michelle F. Link sold 2,208 shares of the company’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total value of $163,016.64. Following the completion of the transaction, the insider now directly owns 6,567 shares in the company, valued at $484,841.61. This represents a 25.16 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 1.40% of the company’s stock.
Maximus Stock Performance
Shares of Maximus stock opened at $73.84 on Friday. The firm’s 50-day moving average is $85.11 and its 200 day moving average is $87.22. The stock has a market cap of $4.45 billion, a price-to-earnings ratio of 14.77 and a beta of 0.73. Maximus, Inc. has a 1 year low of $71.75 and a 1 year high of $93.97. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.49 and a quick ratio of 1.49.
Maximus Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Saturday, November 30th. Shareholders of record on Friday, November 15th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.63%. Maximus’s dividend payout ratio is currently 24.00%.
Maximus Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Read More
- Five stocks we like better than Maximus
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- Pros And Cons Of Monthly Dividend Stocks
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- What Are Dividends? Buy the Best Dividend Stocks
- BlackRock Makes Waves With $12B Private Credit Acquisition
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.